Publications in the NUM
Here you will find a list of publications that were written in connection with the Network of University Medicine in the first and second funding phases.
TODO
TODO
TODO
TODO
TODO
TODO
Cramer K,
others .
Border Restrictions and Cross-Border Care Relations: The Case of Germany and Vietnam.
2021 May.
Cramer K,
others .
Exploring Disruption and Response in International Cross-Country Comparison.
2021 Apr..
Greiner T,
Boender TS,
Greiner F,
others .
Routinedaten aus der medizinischen Versorgung für die Notaufnahme-Surveillance: 1,5 Jahre Notaufnahme-Situationsreport.
2021.
[DOI]
Boor P,
Hartmann A.
Bericht zur Late-Breaking Session Pathologie und COVID-19 [Late Breaking Session Pathology and COVID-19 Report].
Pathologe.
2020;
41(Suppl 2):96-98.
[DOI]
Meerpohl JJ,
Voigt-Radloff S,
Rueschemeyer G,
Balzer F,
Benstoem C,
Binder H,
Boeker M,
Burns J,
Dirnagl U,
Featherstone R,
Fichtner F,
Grundmann H,
Hengel H,
Kempf V,
Kern W,
Kranke P,
Laudi S,
Lieb S,
Maun A,
Mavergames C,
Metzendorf MI,
Nothacker M,
Schmaderer C,
Schmucker C,
Schwingshackl L,
Skoetz N,
Steckelberg A,
Stegemann M,
Strech D,
Moerer O,
Rehfuess E,
Spies C.
CEOsys: Creating an ecosystem for COVID-19 evidence In: Collaborating in response to COVID-19: editorial and methods initiatives across Cochrane.
Cochrane Database of Systematic Reviews.
2020;
12(Suppl 1):
[DOI]
Gagiannis D,
Steinestel J,
Hackenbroch C,
Schreiner B,
Hannemann M,
Bloch W,
Umathum VG,
Gebauer N,
Rother C,
Stahl M,
others .
Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
Front Immunol.
2020;
11587517.
[DOI]
Subbarayan K,
Ulagappan K,
Wickenhauser C,
Seliger B.
Expression and clinical significance of SARS-CoV-2 human targets in neoplastic and non-neoplastic lung tissues.
Curr Cancer Drug Targets.
2020;
[DOI]
Thun S,
Bartschke A,
Sass J,
Kalle C,
Essenwanger A,
Rudolph S.
GECCO: Einigung Auf Datensatz Für COVID-19-Forschung.
EHEALTHCOM.
2020;
514—17.
[File]
Walker A,
Houwaa T,
Wienemann T,
et al .
Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.
Euro Surveillance.
2020;
25(22):
[DOI]
Alm E,
Broberg EK,
Connor T,
et al .
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.
Eurosurveillance.
2020;
25(32):
[DOI]
Abdel-Karim BM,
Pfeuffer N,
Rohde G,
Hinz O.
How and What Can Humans Learn from Being in the Loop?.
KI - Künstliche Intelligenz.
2020;
34(2):199—207.
[DOI]
Scherer J,
Nolden M,
Kleesiek J,
Metzger J,
others .
Joint Imaging Platform for Federated Clinical Data Analytics.
JCO Clin Cancer Inform.
2020;
41027-103.
Schmitt J,
Harst L,
Weber TO,
Sedlmayr M,
Ciesek S,
Apfelbacher C,
Bajbouj M,
Bierbaum V,
Combs S,
Drosten C,
Geraedts M,
Haier J,
Ihle P,
Lieb K,
Rohde G,
Schmidberger H,
Vogelmeier C,
Weber-Carstens S,
Weltermann B,
Wagner M.
Konzept für ein bundesweites Pandemiemanagement im Rahmen des Netzwerks Universitätsmedizin.
German Medical Science GMS Publishing House.
2020;
[DOI]
Bernardes J,
Mishra N,
Tran F,
Bahmer T,
Best L,
Blase J,
Bordoni D,
Franzenburg J,
Geisen U,
Josephs-Spaulding J,
others .
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
Immunity.
2020;
53(6):1296—1314.e9.
[DOI]
Bacher P,
et al .
Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.
Immunity.
2020;
531258—1271.e5.
[DOI]
Krishnaratne S,
Pfadenhauer LM,
Coenen M,
Geffert K,
Jung-Sievers C,
Klinger C,
Kratzer S,
Littlecott H,
Movsisyan A,
Rabe JE,
Rehfuess E,
Sell K,
Strahwald B,
Stratil JM,
Voss S,
Wabnitz K,
Burns J.
Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
Cochrane Database Syst Rev.
2020;
12CD013812.
[DOI]
Augustin M,
Schommers P,
Suárez I,
et al .
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020.
Euro Surveill.
2020;
25(21):
[DOI]
Schneider S,
Piening B,
Nouri-Pasovsky PA,
et al .
SARS-Coronavirus-2 cases in healthcare workers may not regularly originate from patient care: lessons from a university hospital on the underestimated risk of healthcare worker to healthcare worker transmission.
Antimicrob Resist Infect Control.
2020;
9(1):
[DOI]
Bojkova D,
Wagner JUG,
Shumliakivska M,
Aslan GS,
Saleem U,
Hansen A,
Luxán G,
Günther S,
Pham MD,
Krishnan J,
others .
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
Cardiovasc Res.
2020;
116(14):2207-2215.
[DOI]
Gruber A,
Osterrieder N,
Bertzbach L,
Vladimirova D,
Greuel S,
Ihlow ea.
Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–infected Hamsters: What Matters?.
Am. J. Respir. Cell Mol. Biol..
2020;
63856—859.
Erber J,
Kappler V,
Haller B,
et al .
Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany.
MedRxiv.
2020;
[DOI]
Sass J,
Bartschke A,
Lehne M,
Essenwanger A,
Rinaldi E,
Rudolph S,
Heitmann K,
Vehreschild J,
Kalle C,
Thun S.
The German Corona Consensus Dataset (GECCO): a standardized dataset for COVID-19 research in university medicine and beyond.
BMC Med Inform Decis Mak.
2020;
20(1):341.
[DOI]
Mayer M,
Kunhan L,
Zhu M.
China. In:
Jasanoff, S and et al., editors.
Comparative Covid Response: Crisis, Knowledge, Politics.
2020.